Transcatheter Embolization Device Comprehensive Study by Type (Embolization Coils, Coiling-assist Devices, Embolization Particles, Flow Diverter Devices, Liquid Embolics, Accessories), Application (Peripheral Vascular Disease, Neurology, Oncology, Urology), Material (Particle embolic, Coil embolic, Liquid embolic, Others), Embolization Particles Type (Radioembolization Particles, Microspheres, Drug-eluting Beads, Others), Coil Type (Pushable, Detachable), End User (Hospitals, Ambulatory Surgical Centers, Clinics) Players and Region - Global Market Outlook to 2030

Transcatheter Embolization Device Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.81%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Due to upsurging health defects as well as growing instances of cardiac diseases has led to an increase in the demand for Transcatheter embolization devices across the globe. In addition to this, according to the National Cancer Institute at the National Institute of Health (NIH), around 1,658,370 new cancer cases will be diagnosed and around 589,430 people will die in 2015 in the U.S. alone. Taking into account the increasing prevalence of cancer, the global Transcatheter embolization devices market will show a significant demand over the forecasted period. The embolization coil is manufactured to hold PED in the distorted state until the parent vessel doesn’t deploy PED. These devices contain a permanent implant combined with a guidewire-based delivery system. The PED implant is multi-alloy, braided, mesh cylinder woven from cobalt-chromium-nickel alloy wires as well as platinum/tungsten. The embolization coils are produced by tungsten-platinum alloys. Moreover, the use of proximal pusher allows consumers to push PED out of the microcatheter when the wire is advanced.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledBTG PLC (United Kingdom), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Penumbra, Inc. (United States), Cook Medical (United States), Edwards Lifesciences Corporation (United States), Merit Medical Systems Inc. (United States), Johnson & Johnson Services Inc. (United States), Pfizer, Inc. (United States), Stryker Corporation (United States) and Terumo Corporation (Japan)


According to AMA, the market for Transcatheter Embolization Device is expected to register a CAGR of 9.81% during the forecast period to 2027. This growth is primarily driven by Growing Instances of Chronic Diseases and Aging Population across the Globes and Mandatory Diagnosis and Regular Monitoring of Infected Patients will generate Significant Demand.

Globally, a noticeable market trend is evident Introduction to Transcatheter Closures with Comparatively Larger Ducts . Major Players, such as BTG PLC (United Kingdom), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Penumbra, Inc. (United States), Cook Medical (United States), Edwards Lifesciences Corporation (United States), Merit Medical Systems Inc. (United States), Johnson & Johnson Services Inc. (United States), Pfizer, Inc. (United States), Stryker Corporation (United States) and Terumo Corporation (Japan) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

On January 24th, 2019, Boston Scientific Corporation has launched the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia Directional Lead. The new systems, which were recently approved by the U.S. Food and Drug Administration (FDA), feature technology designed to allow physicians to control the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy.

Regulatory Insights:
According to the United States Food and Drug Administration (FDA), Transcatheter Embolization Device Labels must include instructions for use; Compatible transcatheter intracardiac procedure devices; a detailed summary of the clinical testing conducted; a shelf life and storage conditions and many others. Moreover, the device manufacturers must follow registration and list (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Market Drivers
  • Growing Instances of Chronic Diseases and Aging Population across the Globes
  • Mandatory Diagnosis and Regular Monitoring of Infected Patients will generate Significant Demand

Market Trend
  • Introduction to Transcatheter Closures with Comparatively Larger Ducts
  • Consumer Paradigm Shift from Clipping to Coiling has improved the Demand

Restraints
  • Comparatively Costlier Products than Other Healthcare Equipment
  • Stringent Government Regulations and Approval Procedures

Opportunities
Growing Awareness and Attractiveness towards Non-Invasive or Minimally Invasive Surgeries and Upsurging Healthcare Infrastructure in Developing Countries like India and China

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Transcatheter Embolization Device Study Sheds Light on
— The Transcatheter Embolization Device Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Transcatheter Embolization Device industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Transcatheter Embolization Device industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Embolization Coils
  • Coiling-assist Devices
  • Embolization Particles
  • Flow Diverter Devices
  • Liquid Embolics
  • Accessories
By Application
  • Peripheral Vascular Disease
  • Neurology
  • Oncology
  • Urology
By Material
  • Particle embolic
  • Coil embolic
  • Liquid embolic
  • Others

By Embolization Particles Type
  • Radioembolization Particles
  • Microspheres
  • Drug-eluting Beads
  • Others

By Coil Type
  • Pushable
  • Detachable

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Instances of Chronic Diseases and Aging Population across the Globes
      • 3.2.2. Mandatory Diagnosis and Regular Monitoring of Infected Patients will generate Significant Demand
    • 3.3. Market Challenges
      • 3.3.1. Skilled Workforce Required in Operating and Manufacturing Transcatheter Embolization Devices
      • 3.3.2. It helps in Avoiding Complications such as Imprecise Deployment and Catheter Entrapment
    • 3.4. Market Trends
      • 3.4.1. Introduction to Transcatheter Closures with Comparatively Larger Ducts
      • 3.4.2. Consumer Paradigm Shift from Clipping to Coiling has improved the Demand
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transcatheter Embolization Device, by Type, Application, Material, Embolization Particles Type, Coil Type, End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Transcatheter Embolization Device (Value)
      • 5.2.1. Global Transcatheter Embolization Device by: Type (Value)
        • 5.2.1.1. Embolization Coils
        • 5.2.1.2. Coiling-assist Devices
        • 5.2.1.3. Embolization Particles
        • 5.2.1.4. Flow Diverter Devices
        • 5.2.1.5. Liquid Embolics
        • 5.2.1.6. Accessories
      • 5.2.2. Global Transcatheter Embolization Device by: Application (Value)
        • 5.2.2.1. Peripheral Vascular Disease
        • 5.2.2.2. Neurology
        • 5.2.2.3. Oncology
        • 5.2.2.4. Urology
      • 5.2.3. Global Transcatheter Embolization Device by: Material (Value)
        • 5.2.3.1. Particle embolic
        • 5.2.3.2. Coil embolic
        • 5.2.3.3. Liquid embolic
        • 5.2.3.4. Others
      • 5.2.4. Global Transcatheter Embolization Device by: Coil Type (Value)
        • 5.2.4.1. Pushable
        • 5.2.4.2. Detachable
      • 5.2.5. Global Transcatheter Embolization Device by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Ambulatory Surgical Centers
        • 5.2.5.3. Clinics
      • 5.2.6. Global Transcatheter Embolization Device Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Transcatheter Embolization Device (Volume)
      • 5.3.1. Global Transcatheter Embolization Device by: Type (Volume)
        • 5.3.1.1. Embolization Coils
        • 5.3.1.2. Coiling-assist Devices
        • 5.3.1.3. Embolization Particles
        • 5.3.1.4. Flow Diverter Devices
        • 5.3.1.5. Liquid Embolics
        • 5.3.1.6. Accessories
      • 5.3.2. Global Transcatheter Embolization Device by: Application (Volume)
        • 5.3.2.1. Peripheral Vascular Disease
        • 5.3.2.2. Neurology
        • 5.3.2.3. Oncology
        • 5.3.2.4. Urology
      • 5.3.3. Global Transcatheter Embolization Device by: Material (Volume)
        • 5.3.3.1. Particle embolic
        • 5.3.3.2. Coil embolic
        • 5.3.3.3. Liquid embolic
        • 5.3.3.4. Others
      • 5.3.4. Global Transcatheter Embolization Device by: Coil Type (Volume)
        • 5.3.4.1. Pushable
        • 5.3.4.2. Detachable
      • 5.3.5. Global Transcatheter Embolization Device by: End User (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Ambulatory Surgical Centers
        • 5.3.5.3. Clinics
      • 5.3.6. Global Transcatheter Embolization Device Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Transcatheter Embolization Device (Price)
      • 5.4.1. Global Transcatheter Embolization Device by: Type (Price)
  • 6. Transcatheter Embolization Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BTG PLC (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic Plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Penumbra, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cook Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Edwards Lifesciences Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Merit Medical Systems Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Johnson & Johnson Services Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pfizer, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Stryker Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Terumo Corporation (Japan)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Transcatheter Embolization Device Sale, by Type, Application, Material, Embolization Particles Type, Coil Type, End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Transcatheter Embolization Device (Value)
      • 7.2.1. Global Transcatheter Embolization Device by: Type (Value)
        • 7.2.1.1. Embolization Coils
        • 7.2.1.2. Coiling-assist Devices
        • 7.2.1.3. Embolization Particles
        • 7.2.1.4. Flow Diverter Devices
        • 7.2.1.5. Liquid Embolics
        • 7.2.1.6. Accessories
      • 7.2.2. Global Transcatheter Embolization Device by: Application (Value)
        • 7.2.2.1. Peripheral Vascular Disease
        • 7.2.2.2. Neurology
        • 7.2.2.3. Oncology
        • 7.2.2.4. Urology
      • 7.2.3. Global Transcatheter Embolization Device by: Material (Value)
        • 7.2.3.1. Particle embolic
        • 7.2.3.2. Coil embolic
        • 7.2.3.3. Liquid embolic
        • 7.2.3.4. Others
      • 7.2.4. Global Transcatheter Embolization Device by: Coil Type (Value)
        • 7.2.4.1. Pushable
        • 7.2.4.2. Detachable
      • 7.2.5. Global Transcatheter Embolization Device by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Ambulatory Surgical Centers
        • 7.2.5.3. Clinics
      • 7.2.6. Global Transcatheter Embolization Device Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Transcatheter Embolization Device (Volume)
      • 7.3.1. Global Transcatheter Embolization Device by: Type (Volume)
        • 7.3.1.1. Embolization Coils
        • 7.3.1.2. Coiling-assist Devices
        • 7.3.1.3. Embolization Particles
        • 7.3.1.4. Flow Diverter Devices
        • 7.3.1.5. Liquid Embolics
        • 7.3.1.6. Accessories
      • 7.3.2. Global Transcatheter Embolization Device by: Application (Volume)
        • 7.3.2.1. Peripheral Vascular Disease
        • 7.3.2.2. Neurology
        • 7.3.2.3. Oncology
        • 7.3.2.4. Urology
      • 7.3.3. Global Transcatheter Embolization Device by: Material (Volume)
        • 7.3.3.1. Particle embolic
        • 7.3.3.2. Coil embolic
        • 7.3.3.3. Liquid embolic
        • 7.3.3.4. Others
      • 7.3.4. Global Transcatheter Embolization Device by: Coil Type (Volume)
        • 7.3.4.1. Pushable
        • 7.3.4.2. Detachable
      • 7.3.5. Global Transcatheter Embolization Device by: End User (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Ambulatory Surgical Centers
        • 7.3.5.3. Clinics
      • 7.3.6. Global Transcatheter Embolization Device Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Transcatheter Embolization Device (Price)
      • 7.4.1. Global Transcatheter Embolization Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transcatheter Embolization Device: by Type(USD Million)
  • Table 2. Transcatheter Embolization Device Embolization Coils , by Region USD Million (2016-2021)
  • Table 3. Transcatheter Embolization Device Coiling-assist Devices , by Region USD Million (2016-2021)
  • Table 4. Transcatheter Embolization Device Embolization Particles , by Region USD Million (2016-2021)
  • Table 5. Transcatheter Embolization Device Flow Diverter Devices , by Region USD Million (2016-2021)
  • Table 6. Transcatheter Embolization Device Liquid Embolics , by Region USD Million (2016-2021)
  • Table 7. Transcatheter Embolization Device Accessories , by Region USD Million (2016-2021)
  • Table 8. Transcatheter Embolization Device: by Application(USD Million)
  • Table 9. Transcatheter Embolization Device Peripheral Vascular Disease , by Region USD Million (2016-2021)
  • Table 10. Transcatheter Embolization Device Neurology , by Region USD Million (2016-2021)
  • Table 11. Transcatheter Embolization Device Oncology , by Region USD Million (2016-2021)
  • Table 12. Transcatheter Embolization Device Urology , by Region USD Million (2016-2021)
  • Table 13. Transcatheter Embolization Device: by Material(USD Million)
  • Table 14. Transcatheter Embolization Device Particle embolic , by Region USD Million (2016-2021)
  • Table 15. Transcatheter Embolization Device Coil embolic , by Region USD Million (2016-2021)
  • Table 16. Transcatheter Embolization Device Liquid embolic , by Region USD Million (2016-2021)
  • Table 17. Transcatheter Embolization Device Others , by Region USD Million (2016-2021)
  • Table 18. Transcatheter Embolization Device: by Coil Type(USD Million)
  • Table 19. Transcatheter Embolization Device Pushable , by Region USD Million (2016-2021)
  • Table 20. Transcatheter Embolization Device Detachable , by Region USD Million (2016-2021)
  • Table 21. Transcatheter Embolization Device: by End User(USD Million)
  • Table 22. Transcatheter Embolization Device Hospitals , by Region USD Million (2016-2021)
  • Table 23. Transcatheter Embolization Device Ambulatory Surgical Centers , by Region USD Million (2016-2021)
  • Table 24. Transcatheter Embolization Device Clinics , by Region USD Million (2016-2021)
  • Table 25. South America Transcatheter Embolization Device, by Country USD Million (2016-2021)
  • Table 26. South America Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 27. South America Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 28. South America Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 29. South America Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 30. South America Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 31. South America Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 32. Brazil Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 33. Brazil Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 34. Brazil Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 35. Brazil Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 36. Brazil Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 37. Brazil Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 38. Argentina Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 39. Argentina Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 40. Argentina Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 41. Argentina Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 42. Argentina Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 43. Argentina Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 44. Rest of South America Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 45. Rest of South America Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 46. Rest of South America Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 47. Rest of South America Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 48. Rest of South America Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 49. Rest of South America Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 50. Asia Pacific Transcatheter Embolization Device, by Country USD Million (2016-2021)
  • Table 51. Asia Pacific Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 52. Asia Pacific Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 53. Asia Pacific Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 54. Asia Pacific Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 55. Asia Pacific Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 56. Asia Pacific Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 57. China Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 58. China Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 59. China Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 60. China Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 61. China Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 62. China Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 63. Japan Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 64. Japan Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 65. Japan Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 66. Japan Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 67. Japan Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 68. Japan Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 69. India Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 70. India Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 71. India Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 72. India Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 73. India Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 74. India Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 75. South Korea Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 76. South Korea Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 77. South Korea Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 78. South Korea Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 79. South Korea Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 80. South Korea Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 81. Taiwan Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 82. Taiwan Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 83. Taiwan Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 84. Taiwan Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 85. Taiwan Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 86. Taiwan Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 87. Australia Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 88. Australia Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 89. Australia Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 90. Australia Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 91. Australia Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 92. Australia Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 93. Rest of Asia-Pacific Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 94. Rest of Asia-Pacific Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 95. Rest of Asia-Pacific Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 96. Rest of Asia-Pacific Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 97. Rest of Asia-Pacific Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 98. Rest of Asia-Pacific Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 99. Europe Transcatheter Embolization Device, by Country USD Million (2016-2021)
  • Table 100. Europe Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 101. Europe Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 102. Europe Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 103. Europe Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 104. Europe Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 105. Europe Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 106. Germany Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 107. Germany Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 108. Germany Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 109. Germany Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 110. Germany Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 111. Germany Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 112. France Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 113. France Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 114. France Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 115. France Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 116. France Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 117. France Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 118. Italy Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 119. Italy Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 120. Italy Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 121. Italy Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 122. Italy Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 123. Italy Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 124. United Kingdom Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 125. United Kingdom Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 126. United Kingdom Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 127. United Kingdom Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 128. United Kingdom Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 129. United Kingdom Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 130. Netherlands Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 131. Netherlands Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 132. Netherlands Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 133. Netherlands Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 134. Netherlands Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 135. Netherlands Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 136. Rest of Europe Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 137. Rest of Europe Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 138. Rest of Europe Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 139. Rest of Europe Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 140. Rest of Europe Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 141. Rest of Europe Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 142. MEA Transcatheter Embolization Device, by Country USD Million (2016-2021)
  • Table 143. MEA Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 144. MEA Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 145. MEA Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 146. MEA Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 147. MEA Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 148. MEA Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 149. Middle East Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 150. Middle East Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 151. Middle East Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 152. Middle East Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 153. Middle East Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 154. Middle East Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 155. Africa Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 156. Africa Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 157. Africa Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 158. Africa Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 159. Africa Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 160. Africa Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 161. North America Transcatheter Embolization Device, by Country USD Million (2016-2021)
  • Table 162. North America Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 163. North America Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 164. North America Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 165. North America Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 166. North America Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 167. North America Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 168. United States Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 169. United States Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 170. United States Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 171. United States Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 172. United States Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 173. United States Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 174. Canada Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 175. Canada Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 176. Canada Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 177. Canada Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 178. Canada Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 179. Canada Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 180. Mexico Transcatheter Embolization Device, by Type USD Million (2016-2021)
  • Table 181. Mexico Transcatheter Embolization Device, by Application USD Million (2016-2021)
  • Table 182. Mexico Transcatheter Embolization Device, by Material USD Million (2016-2021)
  • Table 183. Mexico Transcatheter Embolization Device, by Embolization Particles Type USD Million (2016-2021)
  • Table 184. Mexico Transcatheter Embolization Device, by Coil Type USD Million (2016-2021)
  • Table 185. Mexico Transcatheter Embolization Device, by End User USD Million (2016-2021)
  • Table 186. Transcatheter Embolization Device Sales: by Type(K Units)
  • Table 187. Transcatheter Embolization Device Sales Embolization Coils , by Region K Units (2016-2021)
  • Table 188. Transcatheter Embolization Device Sales Coiling-assist Devices , by Region K Units (2016-2021)
  • Table 189. Transcatheter Embolization Device Sales Embolization Particles , by Region K Units (2016-2021)
  • Table 190. Transcatheter Embolization Device Sales Flow Diverter Devices , by Region K Units (2016-2021)
  • Table 191. Transcatheter Embolization Device Sales Liquid Embolics , by Region K Units (2016-2021)
  • Table 192. Transcatheter Embolization Device Sales Accessories , by Region K Units (2016-2021)
  • Table 193. Transcatheter Embolization Device Sales: by Application(K Units)
  • Table 194. Transcatheter Embolization Device Sales Peripheral Vascular Disease , by Region K Units (2016-2021)
  • Table 195. Transcatheter Embolization Device Sales Neurology , by Region K Units (2016-2021)
  • Table 196. Transcatheter Embolization Device Sales Oncology , by Region K Units (2016-2021)
  • Table 197. Transcatheter Embolization Device Sales Urology , by Region K Units (2016-2021)
  • Table 198. Transcatheter Embolization Device Sales: by Material(K Units)
  • Table 199. Transcatheter Embolization Device Sales Particle embolic , by Region K Units (2016-2021)
  • Table 200. Transcatheter Embolization Device Sales Coil embolic , by Region K Units (2016-2021)
  • Table 201. Transcatheter Embolization Device Sales Liquid embolic , by Region K Units (2016-2021)
  • Table 202. Transcatheter Embolization Device Sales Others , by Region K Units (2016-2021)
  • Table 203. Transcatheter Embolization Device Sales: by Coil Type(K Units)
  • Table 204. Transcatheter Embolization Device Sales Pushable , by Region K Units (2016-2021)
  • Table 205. Transcatheter Embolization Device Sales Detachable , by Region K Units (2016-2021)
  • Table 206. Transcatheter Embolization Device Sales: by End User(K Units)
  • Table 207. Transcatheter Embolization Device Sales Hospitals , by Region K Units (2016-2021)
  • Table 208. Transcatheter Embolization Device Sales Ambulatory Surgical Centers , by Region K Units (2016-2021)
  • Table 209. Transcatheter Embolization Device Sales Clinics , by Region K Units (2016-2021)
  • Table 210. South America Transcatheter Embolization Device Sales, by Country K Units (2016-2021)
  • Table 211. South America Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 212. South America Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 213. South America Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 214. South America Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 215. South America Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 216. South America Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 217. Brazil Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 218. Brazil Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 219. Brazil Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 220. Brazil Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 221. Brazil Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 222. Brazil Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 223. Argentina Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 224. Argentina Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 225. Argentina Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 226. Argentina Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 227. Argentina Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 228. Argentina Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 229. Rest of South America Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 230. Rest of South America Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 231. Rest of South America Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 232. Rest of South America Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 233. Rest of South America Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 234. Rest of South America Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 235. Asia Pacific Transcatheter Embolization Device Sales, by Country K Units (2016-2021)
  • Table 236. Asia Pacific Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 237. Asia Pacific Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 238. Asia Pacific Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 239. Asia Pacific Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 240. Asia Pacific Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 241. Asia Pacific Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 242. China Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 243. China Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 244. China Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 245. China Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 246. China Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 247. China Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 248. Japan Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 249. Japan Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 250. Japan Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 251. Japan Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 252. Japan Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 253. Japan Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 254. India Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 255. India Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 256. India Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 257. India Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 258. India Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 259. India Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 260. South Korea Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 261. South Korea Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 262. South Korea Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 263. South Korea Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 264. South Korea Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 265. South Korea Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 266. Taiwan Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 267. Taiwan Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 268. Taiwan Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 269. Taiwan Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 270. Taiwan Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 271. Taiwan Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 272. Australia Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 273. Australia Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 274. Australia Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 275. Australia Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 276. Australia Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 277. Australia Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 278. Rest of Asia-Pacific Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 279. Rest of Asia-Pacific Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 280. Rest of Asia-Pacific Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 281. Rest of Asia-Pacific Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 282. Rest of Asia-Pacific Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 283. Rest of Asia-Pacific Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 284. Europe Transcatheter Embolization Device Sales, by Country K Units (2016-2021)
  • Table 285. Europe Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 286. Europe Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 287. Europe Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 288. Europe Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 289. Europe Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 290. Europe Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 291. Germany Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 292. Germany Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 293. Germany Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 294. Germany Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 295. Germany Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 296. Germany Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 297. France Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 298. France Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 299. France Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 300. France Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 301. France Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 302. France Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 303. Italy Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 304. Italy Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 305. Italy Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 306. Italy Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 307. Italy Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 308. Italy Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 309. United Kingdom Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 310. United Kingdom Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 311. United Kingdom Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 312. United Kingdom Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 313. United Kingdom Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 314. United Kingdom Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 315. Netherlands Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 316. Netherlands Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 317. Netherlands Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 318. Netherlands Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 319. Netherlands Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 320. Netherlands Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 321. Rest of Europe Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 322. Rest of Europe Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 323. Rest of Europe Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 324. Rest of Europe Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 325. Rest of Europe Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 326. Rest of Europe Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 327. MEA Transcatheter Embolization Device Sales, by Country K Units (2016-2021)
  • Table 328. MEA Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 329. MEA Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 330. MEA Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 331. MEA Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 332. MEA Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 333. MEA Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 334. Middle East Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 335. Middle East Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 336. Middle East Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 337. Middle East Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 338. Middle East Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 339. Middle East Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 340. Africa Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 341. Africa Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 342. Africa Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 343. Africa Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 344. Africa Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 345. Africa Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 346. North America Transcatheter Embolization Device Sales, by Country K Units (2016-2021)
  • Table 347. North America Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 348. North America Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 349. North America Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 350. North America Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 351. North America Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 352. North America Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 353. United States Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 354. United States Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 355. United States Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 356. United States Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 357. United States Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 358. United States Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 359. Canada Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 360. Canada Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 361. Canada Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 362. Canada Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 363. Canada Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 364. Canada Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 365. Mexico Transcatheter Embolization Device Sales, by Type K Units (2016-2021)
  • Table 366. Mexico Transcatheter Embolization Device Sales, by Application K Units (2016-2021)
  • Table 367. Mexico Transcatheter Embolization Device Sales, by Material K Units (2016-2021)
  • Table 368. Mexico Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2016-2021)
  • Table 369. Mexico Transcatheter Embolization Device Sales, by Coil Type K Units (2016-2021)
  • Table 370. Mexico Transcatheter Embolization Device Sales, by End User K Units (2016-2021)
  • Table 371. Transcatheter Embolization Device: by Type(USD/Units)
  • Table 372. Company Basic Information, Sales Area and Its Competitors
  • Table 373. Company Basic Information, Sales Area and Its Competitors
  • Table 374. Company Basic Information, Sales Area and Its Competitors
  • Table 375. Company Basic Information, Sales Area and Its Competitors
  • Table 376. Company Basic Information, Sales Area and Its Competitors
  • Table 377. Company Basic Information, Sales Area and Its Competitors
  • Table 378. Company Basic Information, Sales Area and Its Competitors
  • Table 379. Company Basic Information, Sales Area and Its Competitors
  • Table 380. Company Basic Information, Sales Area and Its Competitors
  • Table 381. Company Basic Information, Sales Area and Its Competitors
  • Table 382. Company Basic Information, Sales Area and Its Competitors
  • Table 383. Transcatheter Embolization Device: by Type(USD Million)
  • Table 384. Transcatheter Embolization Device Embolization Coils , by Region USD Million (2022-2027)
  • Table 385. Transcatheter Embolization Device Coiling-assist Devices , by Region USD Million (2022-2027)
  • Table 386. Transcatheter Embolization Device Embolization Particles , by Region USD Million (2022-2027)
  • Table 387. Transcatheter Embolization Device Flow Diverter Devices , by Region USD Million (2022-2027)
  • Table 388. Transcatheter Embolization Device Liquid Embolics , by Region USD Million (2022-2027)
  • Table 389. Transcatheter Embolization Device Accessories , by Region USD Million (2022-2027)
  • Table 390. Transcatheter Embolization Device: by Application(USD Million)
  • Table 391. Transcatheter Embolization Device Peripheral Vascular Disease , by Region USD Million (2022-2027)
  • Table 392. Transcatheter Embolization Device Neurology , by Region USD Million (2022-2027)
  • Table 393. Transcatheter Embolization Device Oncology , by Region USD Million (2022-2027)
  • Table 394. Transcatheter Embolization Device Urology , by Region USD Million (2022-2027)
  • Table 395. Transcatheter Embolization Device: by Material(USD Million)
  • Table 396. Transcatheter Embolization Device Particle embolic , by Region USD Million (2022-2027)
  • Table 397. Transcatheter Embolization Device Coil embolic , by Region USD Million (2022-2027)
  • Table 398. Transcatheter Embolization Device Liquid embolic , by Region USD Million (2022-2027)
  • Table 399. Transcatheter Embolization Device Others , by Region USD Million (2022-2027)
  • Table 400. Transcatheter Embolization Device: by Coil Type(USD Million)
  • Table 401. Transcatheter Embolization Device Pushable , by Region USD Million (2022-2027)
  • Table 402. Transcatheter Embolization Device Detachable , by Region USD Million (2022-2027)
  • Table 403. Transcatheter Embolization Device: by End User(USD Million)
  • Table 404. Transcatheter Embolization Device Hospitals , by Region USD Million (2022-2027)
  • Table 405. Transcatheter Embolization Device Ambulatory Surgical Centers , by Region USD Million (2022-2027)
  • Table 406. Transcatheter Embolization Device Clinics , by Region USD Million (2022-2027)
  • Table 407. South America Transcatheter Embolization Device, by Country USD Million (2022-2027)
  • Table 408. South America Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 409. South America Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 410. South America Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 411. South America Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 412. South America Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 413. South America Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 414. Brazil Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 415. Brazil Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 416. Brazil Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 417. Brazil Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 418. Brazil Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 419. Brazil Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 420. Argentina Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 421. Argentina Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 422. Argentina Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 423. Argentina Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 424. Argentina Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 425. Argentina Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 426. Rest of South America Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 427. Rest of South America Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 428. Rest of South America Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 429. Rest of South America Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 430. Rest of South America Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 431. Rest of South America Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 432. Asia Pacific Transcatheter Embolization Device, by Country USD Million (2022-2027)
  • Table 433. Asia Pacific Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 434. Asia Pacific Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 435. Asia Pacific Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 436. Asia Pacific Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 437. Asia Pacific Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 438. Asia Pacific Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 439. China Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 440. China Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 441. China Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 442. China Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 443. China Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 444. China Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 445. Japan Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 446. Japan Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 447. Japan Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 448. Japan Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 449. Japan Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 450. Japan Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 451. India Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 452. India Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 453. India Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 454. India Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 455. India Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 456. India Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 457. South Korea Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 458. South Korea Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 459. South Korea Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 460. South Korea Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 461. South Korea Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 462. South Korea Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 463. Taiwan Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 464. Taiwan Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 465. Taiwan Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 466. Taiwan Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 467. Taiwan Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 468. Taiwan Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 469. Australia Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 470. Australia Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 471. Australia Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 472. Australia Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 473. Australia Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 474. Australia Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 475. Rest of Asia-Pacific Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 476. Rest of Asia-Pacific Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 477. Rest of Asia-Pacific Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 478. Rest of Asia-Pacific Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 479. Rest of Asia-Pacific Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 480. Rest of Asia-Pacific Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 481. Europe Transcatheter Embolization Device, by Country USD Million (2022-2027)
  • Table 482. Europe Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 483. Europe Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 484. Europe Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 485. Europe Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 486. Europe Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 487. Europe Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 488. Germany Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 489. Germany Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 490. Germany Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 491. Germany Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 492. Germany Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 493. Germany Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 494. France Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 495. France Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 496. France Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 497. France Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 498. France Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 499. France Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 500. Italy Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 501. Italy Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 502. Italy Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 503. Italy Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 504. Italy Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 505. Italy Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 506. United Kingdom Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 507. United Kingdom Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 508. United Kingdom Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 509. United Kingdom Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 510. United Kingdom Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 511. United Kingdom Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 512. Netherlands Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 513. Netherlands Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 514. Netherlands Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 515. Netherlands Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 516. Netherlands Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 517. Netherlands Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 518. Rest of Europe Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 519. Rest of Europe Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 520. Rest of Europe Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 521. Rest of Europe Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 522. Rest of Europe Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 523. Rest of Europe Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 524. MEA Transcatheter Embolization Device, by Country USD Million (2022-2027)
  • Table 525. MEA Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 526. MEA Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 527. MEA Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 528. MEA Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 529. MEA Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 530. MEA Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 531. Middle East Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 532. Middle East Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 533. Middle East Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 534. Middle East Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 535. Middle East Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 536. Middle East Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 537. Africa Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 538. Africa Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 539. Africa Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 540. Africa Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 541. Africa Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 542. Africa Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 543. North America Transcatheter Embolization Device, by Country USD Million (2022-2027)
  • Table 544. North America Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 545. North America Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 546. North America Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 547. North America Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 548. North America Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 549. North America Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 550. United States Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 551. United States Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 552. United States Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 553. United States Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 554. United States Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 555. United States Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 556. Canada Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 557. Canada Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 558. Canada Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 559. Canada Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 560. Canada Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 561. Canada Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 562. Mexico Transcatheter Embolization Device, by Type USD Million (2022-2027)
  • Table 563. Mexico Transcatheter Embolization Device, by Application USD Million (2022-2027)
  • Table 564. Mexico Transcatheter Embolization Device, by Material USD Million (2022-2027)
  • Table 565. Mexico Transcatheter Embolization Device, by Embolization Particles Type USD Million (2022-2027)
  • Table 566. Mexico Transcatheter Embolization Device, by Coil Type USD Million (2022-2027)
  • Table 567. Mexico Transcatheter Embolization Device, by End User USD Million (2022-2027)
  • Table 568. Transcatheter Embolization Device Sales: by Type(K Units)
  • Table 569. Transcatheter Embolization Device Sales Embolization Coils , by Region K Units (2022-2027)
  • Table 570. Transcatheter Embolization Device Sales Coiling-assist Devices , by Region K Units (2022-2027)
  • Table 571. Transcatheter Embolization Device Sales Embolization Particles , by Region K Units (2022-2027)
  • Table 572. Transcatheter Embolization Device Sales Flow Diverter Devices , by Region K Units (2022-2027)
  • Table 573. Transcatheter Embolization Device Sales Liquid Embolics , by Region K Units (2022-2027)
  • Table 574. Transcatheter Embolization Device Sales Accessories , by Region K Units (2022-2027)
  • Table 575. Transcatheter Embolization Device Sales: by Application(K Units)
  • Table 576. Transcatheter Embolization Device Sales Peripheral Vascular Disease , by Region K Units (2022-2027)
  • Table 577. Transcatheter Embolization Device Sales Neurology , by Region K Units (2022-2027)
  • Table 578. Transcatheter Embolization Device Sales Oncology , by Region K Units (2022-2027)
  • Table 579. Transcatheter Embolization Device Sales Urology , by Region K Units (2022-2027)
  • Table 580. Transcatheter Embolization Device Sales: by Material(K Units)
  • Table 581. Transcatheter Embolization Device Sales Particle embolic , by Region K Units (2022-2027)
  • Table 582. Transcatheter Embolization Device Sales Coil embolic , by Region K Units (2022-2027)
  • Table 583. Transcatheter Embolization Device Sales Liquid embolic , by Region K Units (2022-2027)
  • Table 584. Transcatheter Embolization Device Sales Others , by Region K Units (2022-2027)
  • Table 585. Transcatheter Embolization Device Sales: by Coil Type(K Units)
  • Table 586. Transcatheter Embolization Device Sales Pushable , by Region K Units (2022-2027)
  • Table 587. Transcatheter Embolization Device Sales Detachable , by Region K Units (2022-2027)
  • Table 588. Transcatheter Embolization Device Sales: by End User(K Units)
  • Table 589. Transcatheter Embolization Device Sales Hospitals , by Region K Units (2022-2027)
  • Table 590. Transcatheter Embolization Device Sales Ambulatory Surgical Centers , by Region K Units (2022-2027)
  • Table 591. Transcatheter Embolization Device Sales Clinics , by Region K Units (2022-2027)
  • Table 592. South America Transcatheter Embolization Device Sales, by Country K Units (2022-2027)
  • Table 593. South America Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 594. South America Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 595. South America Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 596. South America Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 597. South America Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 598. South America Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 599. Brazil Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 600. Brazil Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 601. Brazil Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 602. Brazil Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 603. Brazil Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 604. Brazil Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 605. Argentina Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 606. Argentina Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 607. Argentina Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 608. Argentina Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 609. Argentina Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 610. Argentina Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 611. Rest of South America Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 612. Rest of South America Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 613. Rest of South America Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 614. Rest of South America Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 615. Rest of South America Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 616. Rest of South America Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 617. Asia Pacific Transcatheter Embolization Device Sales, by Country K Units (2022-2027)
  • Table 618. Asia Pacific Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 619. Asia Pacific Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 620. Asia Pacific Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 621. Asia Pacific Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 622. Asia Pacific Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 623. Asia Pacific Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 624. China Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 625. China Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 626. China Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 627. China Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 628. China Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 629. China Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 630. Japan Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
  • Table 631. Japan Transcatheter Embolization Device Sales, by Application K Units (2022-2027)
  • Table 632. Japan Transcatheter Embolization Device Sales, by Material K Units (2022-2027)
  • Table 633. Japan Transcatheter Embolization Device Sales, by Embolization Particles Type K Units (2022-2027)
  • Table 634. Japan Transcatheter Embolization Device Sales, by Coil Type K Units (2022-2027)
  • Table 635. Japan Transcatheter Embolization Device Sales, by End User K Units (2022-2027)
  • Table 636. India Transcatheter Embolization Device Sales, by Type K Units (2022-2027)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transcatheter Embolization Device: by Type USD Million (2016-2021)
  • Figure 5. Global Transcatheter Embolization Device: by Application USD Million (2016-2021)
  • Figure 6. Global Transcatheter Embolization Device: by Material USD Million (2016-2021)
  • Figure 7. Global Transcatheter Embolization Device: by Coil Type USD Million (2016-2021)
  • Figure 8. Global Transcatheter Embolization Device: by End User USD Million (2016-2021)
  • Figure 9. South America Transcatheter Embolization Device Share (%), by Country
  • Figure 10. Asia Pacific Transcatheter Embolization Device Share (%), by Country
  • Figure 11. Europe Transcatheter Embolization Device Share (%), by Country
  • Figure 12. MEA Transcatheter Embolization Device Share (%), by Country
  • Figure 13. North America Transcatheter Embolization Device Share (%), by Country
  • Figure 14. Global Transcatheter Embolization Device: by Type K Units (2016-2021)
  • Figure 15. Global Transcatheter Embolization Device: by Application K Units (2016-2021)
  • Figure 16. Global Transcatheter Embolization Device: by Material K Units (2016-2021)
  • Figure 17. Global Transcatheter Embolization Device: by Coil Type K Units (2016-2021)
  • Figure 18. Global Transcatheter Embolization Device: by End User K Units (2016-2021)
  • Figure 19. South America Transcatheter Embolization Device Share (%), by Country
  • Figure 20. Asia Pacific Transcatheter Embolization Device Share (%), by Country
  • Figure 21. Europe Transcatheter Embolization Device Share (%), by Country
  • Figure 22. MEA Transcatheter Embolization Device Share (%), by Country
  • Figure 23. North America Transcatheter Embolization Device Share (%), by Country
  • Figure 24. Global Transcatheter Embolization Device: by Type USD/Units (2016-2021)
  • Figure 25. Global Transcatheter Embolization Device share by Players 2021 (%)
  • Figure 26. Global Transcatheter Embolization Device share by Players (Top 3) 2021(%)
  • Figure 27. Global Transcatheter Embolization Device share by Players (Top 5) 2021(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. BTG PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. BTG PLC (United Kingdom) Revenue: by Geography 2021
  • Figure 31. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 33. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 34. Medtronic Plc (Ireland) Revenue: by Geography 2021
  • Figure 35. Penumbra, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Penumbra, Inc. (United States) Revenue: by Geography 2021
  • Figure 37. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cook Medical (United States) Revenue: by Geography 2021
  • Figure 39. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2021
  • Figure 41. Merit Medical Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Merit Medical Systems Inc. (United States) Revenue: by Geography 2021
  • Figure 43. Johnson & Johnson Services Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Johnson & Johnson Services Inc. (United States) Revenue: by Geography 2021
  • Figure 45. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Pfizer, Inc. (United States) Revenue: by Geography 2021
  • Figure 47. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 48. Stryker Corporation (United States) Revenue: by Geography 2021
  • Figure 49. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 50. Terumo Corporation (Japan) Revenue: by Geography 2021
  • Figure 51. Global Transcatheter Embolization Device: by Type USD Million (2022-2027)
  • Figure 52. Global Transcatheter Embolization Device: by Application USD Million (2022-2027)
  • Figure 53. Global Transcatheter Embolization Device: by Material USD Million (2022-2027)
  • Figure 54. Global Transcatheter Embolization Device: by Coil Type USD Million (2022-2027)
  • Figure 55. Global Transcatheter Embolization Device: by End User USD Million (2022-2027)
  • Figure 56. South America Transcatheter Embolization Device Share (%), by Country
  • Figure 57. Asia Pacific Transcatheter Embolization Device Share (%), by Country
  • Figure 58. Europe Transcatheter Embolization Device Share (%), by Country
  • Figure 59. MEA Transcatheter Embolization Device Share (%), by Country
  • Figure 60. North America Transcatheter Embolization Device Share (%), by Country
  • Figure 61. Global Transcatheter Embolization Device: by Type K Units (2022-2027)
  • Figure 62. Global Transcatheter Embolization Device: by Application K Units (2022-2027)
  • Figure 63. Global Transcatheter Embolization Device: by Material K Units (2022-2027)
  • Figure 64. Global Transcatheter Embolization Device: by Coil Type K Units (2022-2027)
  • Figure 65. Global Transcatheter Embolization Device: by End User K Units (2022-2027)
  • Figure 66. South America Transcatheter Embolization Device Share (%), by Country
  • Figure 67. Asia Pacific Transcatheter Embolization Device Share (%), by Country
  • Figure 68. Europe Transcatheter Embolization Device Share (%), by Country
  • Figure 69. MEA Transcatheter Embolization Device Share (%), by Country
  • Figure 70. North America Transcatheter Embolization Device Share (%), by Country
  • Figure 71. Global Transcatheter Embolization Device: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • BTG PLC (United Kingdom)
  • Boston Scientific Corporation (United States)
  • Medtronic Plc (Ireland)
  • Penumbra, Inc. (United States)
  • Cook Medical (United States)
  • Edwards Lifesciences Corporation (United States)
  • Merit Medical Systems Inc. (United States)
  • Johnson & Johnson Services Inc. (United States)
  • Pfizer, Inc. (United States)
  • Stryker Corporation (United States)
  • Terumo Corporation (Japan)
Additional players considered in the study are as follows:
Sirtex Medical Limited (Australia) , Abbott Laboratories (United States) , Neovasc Inc. (Canada) , Mitrassist Medical (Israel) , Micro Interventional Devices, Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 116 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Transcatheter Embolization Device market are BTG PLC (United Kingdom), Boston Scientific Corporation (United States), Medtronic Plc (Ireland), Penumbra, Inc. (United States), Cook Medical (United States), Edwards Lifesciences Corporation (United States), Merit Medical Systems Inc. (United States), Johnson & Johnson Services Inc. (United States), Pfizer, Inc. (United States), Stryker Corporation (United States) and Terumo Corporation (Japan), to name a few.
"Skilled Workforce Required in Operating and Manufacturing Transcatheter Embolization Devices " is seen as one of major challenge by many Industry Players of Transcatheter Embolization Device Market
The Transcatheter Embolization Device market is expected to see a CAGR of 9.81% during projected year 2021 to 2027.

Know More About Global Transcatheter Embolization Device Market Report?